Close Menu

This story has been updated from a previous version to include comments made by NantHealth executives during the company's earnings call.

NEW YORK – NantHealth reported after the close of the market Thursday that its revenue rose 6 percent during the 2019 first quarter to $23.7 million from $22.3 million in the same period in 2018.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.